Careers Contact Us

Contact Pfizer Media Relations

This information is intended for media professionals.

This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists.

If you are not a journalist, please visit the Contact Page and consult the appropriate Pfizer contact.

Phone: (212) 573-1226

Email Pfizer Media Relations


For specific media inquiries:
Europe/Africa/Middle East, email wwce@pfizer.com

You can also visit our Pfizer Worldwide Web Sites.



Contact

Responsibility

Key Focus Areas / Issues
(Not all-inclusive)
Ray Kerins
Ray Kerins
W: 212-733-9203
C: 917-324-0080
Ray.Kerins@pfizer.com
Vice President, External Affairs & Worldwide Communications  
Chris Loder
Chris Loder
W: 212-733-7897
C: 347-453-8199
Christopher.Loder@pfizer.com
Head of Media Relations - United States Litigation; Counterfeiting; Oncology
Anne Wilson
Anne Wilson
W: 212-733-5017
C: 202-297-7661
Anne.E.Wilson@pfizer.com
Head Medical & Science Media Relations  
Kristen Neese
Kristen Neese
W: 212-733-8926
C: 646-299-2526
Kristen.E.Neese@pfizer.com
Head Regulatory & Policy Media Relations  
Joan Campion
W: 212-733-2798
C: 201-761-9384
Joan.Campion@pfizer.com
Corporate/Financial Media Relations Finance; Earnings/SEC Filings; Corporate Governance; Business Development
Sally Beatty
W: 212-733-6566
C: 347-330-7867
Sally.Beatty@pfizer.com
Primary Care Lipitor, Viagra, Chantix
Mackay Jimeson
Mackay Jimeson
W: 212-733-2324
C: 347-439-5647
Mackay.Jimeson@pfizer.com
Primary Care Lyrica, Celebrex, Spiriva, Toviaz, Dimebon, Apixiban, Tanezumab
Gwen Fisher
Gwen Fisher
W: 484-865-5160
C: 215-407-1548
Gwen.Fisher@pfizer.com
Specialty Care Prevnar, Prevenar 13, Tygacil, Revatio, Geodon, Enbrel, JAK-3 inhibitors
Rick ChambersRick Chambers
W: 269-833-6387
C:269-760-0770
Richard.T.Chambers@pfizer.com
GGlobal Manufacturing; Global Engineering; U.S. Regional Support Environmental; Manufacturing sites
Liz Power
Liz Power
W: 860-732-4987
C: 860-501-3849
Elizabeth.Power@pfizer.com
PGRD Medical and Science Communications
Rick Goulart
Rick Goulart
W: 212-733-7457
C: 860-501-3391
Rick.Goulart@pfizer.com
Animal Health  
Samantha Cummis
Samantha Cummis
W: 212-733-6924
C: 917-679-8413
Samantha.Cummis@pfizer.com
Business Development, Strategy & Innovation  
Andrew Topen
Andrew Topen
W: 44 1737 332236
C: 44 7967 757688
Andrew.Topen@pfizer.com
Head EU Media Relations  
Monica Pinuela
W: 34 91 490 99 20
C: 34 647 37 62 85
Monica.Pinuela@pfizer.com
Europe R&D/science; Product Communications
Tyrene Frederick-Mack
Tyrene Frederick-Mack
W: 212-733-3848
C: 917-327-7821
Tyrene.Frederick-Mack@pfizer.com
Latin America  
Marco Winkler
Marco Winkler
W: 212-733-9313
C: 646-318-1264
Marco.Winkler@pfizer.com
Eastern Europe, Middle East, Africa  
Neena Moorjani
W: 852 2287 9939
C: 852 9038 0150
Neena.Moorjani@pfizer.com
Asia Pacific  

Stock Quote Disclaimer

20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.

Text SizeAAA
Pfizer Stock Price

Stock Symbol: PFE    Stock Exchange: NYSE

Stock Quote at: Mar 9 2010 4:00PM

Last  17.23Change  -0.12
%Change-0.69Vol.54,551,200
Day High17.3252 Wk. High20.36
Day Low17.1552 Wk. Low12.59
Open17.27Mkt. Cap(Bil)139.01
Prev. Close17.35
Pfizer Annual Report
Pfizer Annual Report

Pfizer Annual Review:
Doing Things Differently

We are becoming the Pfizer we are meant to be — one that can offer healthy solutions at every stage of life.